---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-26-000007"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:54:05.737978+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# ICU Medical Q4: revenue $540.7M (-14% YoY), GAAP loss $(0.64)/share, adj EPS $1.91

## Summary
- Revenue $540.7M vs $629.8M in Q4 2024, down 14.1% YoY.
- GAAP net loss $(15.7)M, or $(0.64) per diluted share, improving from $(23.8)M loss in Q4 2024.
- Adjusted diluted EPS $1.91, down from $2.11; Adjusted EBITDA $98.2M vs $105.5M.
- GAAP gross margin improved to 38% from 36%.
- Fiscal 2026 guidance provided but numerical details not included in filing excerpt.

## SEC filing metadata
- accession: 0000883984-26-000007
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398426000007/0000883984-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398426000007/icui-20260219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-26-000007
- JSON: https://secwatch.observer/filing/0000883984-26-000007.json
- Plain text: https://secwatch.observer/filing/0000883984-26-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.